Use

Measures antibodies of immunoglobulin classes IgG, IgA, and IgM that target beta‑2‑glycoprotein I, aiding in evaluation of antiphospholipid syndrome—an autoimmune clotting disorder associated with thrombosis risk and pregnancy loss. It supports diagnosis of APS, investigation of unexplained thrombotic events (e.g., DVT, stroke, PE), recurrent pregnancy loss, and monitoring of autoimmune conditions such as lupus.